2,3-bis(4-hydroxyphenyl)-propionitrile and Carcinoma, Non-Small Cell Lung

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gubish, CT; Hershberger, PA; Kanterewicz, B; Land, S; Nichols, M; Rothstein, ME; Shuai, Y; Siegfried, JM; Stabile, LP	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Carcinoma, Non-Small Cell Lung

Article	Year
Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. The Journal of steroid biochemistry and molecular biology, 2009, Volume: 116, Issue:1-2 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Estrogen Receptor beta; Genistein; Ginsenosides; Humans; Ligands; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Nitriles; Protein Kinase Inhibitors; Sapogenins; Transcription Factors; Transcription, Genetic; Transfection	2009

Article

Year

Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.

The Journal of steroid biochemistry and molecular biology, 2009, Volume: 116, Issue:1-2

Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Estrogen Receptor beta; Genistein; Ginsenosides; Humans; Ligands; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Nitriles; Protein Kinase Inhibitors; Sapogenins; Transcription Factors; Transcription, Genetic; Transfection

2009